Page last updated: 2024-09-03

lestaurtinib and indazoles

lestaurtinib has been researched along with indazoles in 2 studies

Compound Research Comparison

Studies (lestaurtinib)	Trials (lestaurtinib)	Recent Studies (post-2010) (lestaurtinib)	Studies (indazoles)	Trials (indazoles)	Recent Studies (post-2010) (indazoles)
124	12	63	5,609	550	3,265

Protein Interaction Comparison

Protein	Taxonomy	indazoles (IC50)
Chain A, Cell Division Protein Kinase 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, Cell Division Protein Kinase 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, CELL DIVISION PROTEIN KINASE 2	Homo sapiens (human)	185
Chain A, Cell Division Protein Kinase 2	Homo sapiens (human)	185

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Levis, M; Murphy, KM; Pratz, KW; Rajkhowa, T; Sato, T; Stine, A	1
Burnett, A; Galkin, S; Knapper, S; Levis, M; Sato, T; Small, D; Smith, BD; White, P; Yang, X	1

Other Studies

2 other study(ies) available for lestaurtinib and indazoles

Article	Year
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. Blood, 2010, Feb-18, Volume: 115, Issue:7 Topics: Alleles; Antineoplastic Agents; Benzenesulfonates; Benzothiazoles; Carbazoles; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Indoles; Leukemia, Myeloid, Acute; Mutation; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Pyridines; Pyrroles; Sorafenib; Staurosporine; Sunitinib	2010
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo. Blood, 2011, Mar-24, Volume: 117, Issue:12 Topics: Antineoplastic Agents; Benzenesulfonates; Carbazoles; Cells, Cultured; Drug Antagonism; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Membrane Proteins; Multicenter Studies as Topic; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Sorafenib; Staurosporine; Treatment Outcome	2011

Article

Year

FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.

Blood, 2010, Feb-18, Volume: 115, Issue:7

Topics: Alleles; Antineoplastic Agents; Benzenesulfonates; Benzothiazoles; Carbazoles; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Indoles; Leukemia, Myeloid, Acute; Mutation; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Pyridines; Pyrroles; Sorafenib; Staurosporine; Sunitinib

2010

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo.

Blood, 2011, Mar-24, Volume: 117, Issue:12

Topics: Antineoplastic Agents; Benzenesulfonates; Carbazoles; Cells, Cultured; Drug Antagonism; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Membrane Proteins; Multicenter Studies as Topic; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Sorafenib; Staurosporine; Treatment Outcome

2011